Advances in human induced pluripotent stem cell (hiPSC)-based disease modelling in cardiogenetics

Human induced pluripotent stem cell (hiPSC)-based disease modelling has significantly advanced the field of cardiogenetics, providing a precise, patient-specific platform for studying genetic causes of heart diseases. Coupled with genome editing technologies such as CRISPR/Cas, hiPSC-based models no...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Seeger, Timon (VerfasserIn) , Hoffmann, Sandra (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 8. April 2025
In: Medizinische Genetik
Year: 2025, Jahrgang: 37, Heft: 2, Pages: 137-146
ISSN:1863-5490
DOI:10.1515/medgen-2025-2009
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1515/medgen-2025-2009
Verlag, kostenfrei, Volltext: https://www.degruyterbrill.com/document/doi/10.1515/medgen-2025-2009/html
Volltext
Verfasserangaben:Timon Seeger, Sandra Hoffmann

MARC

LEADER 00000naa a2200000 c 4500
001 1934919349
003 DE-627
005 20250828112941.0
007 cr uuu---uuuuu
008 250828s2025 xx |||||o 00| ||eng c
024 7 |a 10.1515/medgen-2025-2009  |2 doi 
035 |a (DE-627)1934919349 
035 |a (DE-599)KXP1934919349 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Seeger, Timon  |d 1979-  |e VerfasserIn  |0 (DE-588)135748178  |0 (DE-627)693749148  |0 (DE-576)284473766  |4 aut 
245 1 0 |a Advances in human induced pluripotent stem cell (hiPSC)-based disease modelling in cardiogenetics  |c Timon Seeger, Sandra Hoffmann 
264 1 |c 8. April 2025 
300 |b Illustrationen 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 28.08.2025 
520 |a Human induced pluripotent stem cell (hiPSC)-based disease modelling has significantly advanced the field of cardiogenetics, providing a precise, patient-specific platform for studying genetic causes of heart diseases. Coupled with genome editing technologies such as CRISPR/Cas, hiPSC-based models not only allow the creation of isogenic lines to study mutation-specific cardiac phenotypes, but also enable the targeted modulation of gene expression to explore the effects of genetic and epigenetic deficits at the cellular and molecular level. hiPSC-based models of heart disease range from two-dimensional cultures of hiPSC-derived cardiovascular cell types, such as various cardiomyocyte subtypes, endothelial cells, pericytes, vascular smooth muscle cells, cardiac fibroblasts, immune cells, etc., to cardiac tissue cultures including organoids, microtissues, engineered heart tissues, and microphysiological systems. These models are further enhanced by multi-omics approaches, integrating genomic, transcriptomic, epigenomic, proteomic, and metabolomic data to provide a comprehensive view of disease mechanisms. In particular, advances in cardiovascular tissue engineering enable the development of more physiologically relevant systems that recapitulate native heart architecture and function, allowing for more accurate modelling of cardiac disease, drug screening, and toxicity testing, with the overall goal of personalised medical approaches, where therapies can be tailored to individual genetic profiles. Despite significant progress, challenges remain in the maturation of hiPSC-derived cardiomyocytes and the complexity of reproducing adult heart conditions. Here, we provide a concise update on the most advanced methods of hiPSC-based disease modelling in cardiogenetics, with a focus on genome editing and cardiac tissue engineering. 
650 4 |a cardiac tissue engineering 
650 4 |a cardiogenetics 
650 4 |a disease modelling 
650 4 |a genome editing 
650 4 |a hiPSCs 
700 1 |a Hoffmann, Sandra  |e VerfasserIn  |0 (DE-588)1045033618  |0 (DE-627)77353556X  |0 (DE-576)398345406  |4 aut 
773 0 8 |i Enthalten in  |t Medizinische Genetik  |d Berlin : de Gruyter, 1998  |g 37(2025), 2, Seite 137-146  |h Online-Ressource  |w (DE-627)39761571X  |w (DE-600)2163157-8  |w (DE-576)265030536  |x 1863-5490  |7 nnas  |a Advances in human induced pluripotent stem cell (hiPSC)-based disease modelling in cardiogenetics 
773 1 8 |g volume:37  |g year:2025  |g number:2  |g pages:137-146  |g extent:10  |a Advances in human induced pluripotent stem cell (hiPSC)-based disease modelling in cardiogenetics 
856 4 0 |u https://doi.org/10.1515/medgen-2025-2009  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.degruyterbrill.com/document/doi/10.1515/medgen-2025-2009/html  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20250828 
993 |a Article 
994 |a 2025 
998 |g 1045033618  |a Hoffmann, Sandra  |m 1045033618:Hoffmann, Sandra  |d 910000  |d 911500  |d 50000  |e 910000PH1045033618  |e 911500PH1045033618  |e 50000PH1045033618  |k 0/910000/  |k 1/910000/911500/  |k 0/50000/  |p 2  |y j 
998 |g 135748178  |a Seeger, Timon  |m 135748178:Seeger, Timon  |d 910000  |d 910100  |e 910000PS135748178  |e 910100PS135748178  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1934919349  |e 4765123006 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title_sort":"Advances in human induced pluripotent stem cell (hiPSC)-based disease modelling in cardiogenetics","title":"Advances in human induced pluripotent stem cell (hiPSC)-based disease modelling in cardiogenetics"}],"person":[{"roleDisplay":"VerfasserIn","given":"Timon","display":"Seeger, Timon","family":"Seeger","role":"aut"},{"role":"aut","family":"Hoffmann","display":"Hoffmann, Sandra","roleDisplay":"VerfasserIn","given":"Sandra"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"name":{"displayForm":["Timon Seeger, Sandra Hoffmann"]},"recId":"1934919349","id":{"eki":["1934919349"],"doi":["10.1515/medgen-2025-2009"]},"language":["eng"],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 12.04.2023"],"language":["ger"],"disp":"Advances in human induced pluripotent stem cell (hiPSC)-based disease modelling in cardiogeneticsMedizinische Genetik","corporate":[{"role":"isb","display":"Berufsverband Medizinische Genetik","roleDisplay":"Herausgebendes Organ"}],"origin":[{"publisher":"de Gruyter ; Springer","dateIssuedDisp":"1998-","publisherPlace":"Berlin ; Berlin ; Heidelberg","dateIssuedKey":"1998"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"part":{"pages":"137-146","year":"2025","issue":"2","text":"37(2025), 2, Seite 137-146","extent":"10","volume":"37"},"title":[{"title_sort":"Medizinische Genetik","title":"Medizinische Genetik"}],"id":{"issn":["1863-5490"],"eki":["39761571X"],"zdb":["2163157-8"]},"recId":"39761571X","name":{"displayForm":["Berufsverband Medizinische Genetik e.V."]},"pubHistory":["Nachgewiesen 10.1998 -"]}],"physDesc":[{"extent":"10 S.","noteIll":"Illustrationen"}],"note":["Gesehen am 28.08.2025"],"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"8. April 2025"}]} 
SRT |a SEEGERTIMOADVANCESIN8202